Data from a large retrospective US clinical care cohort study of 1,772,900 people with CKD (either low estimated glomerular filtration rate [eGFR] or abnormal albuminuria) representative of the general population was able to provide rates of hyperkalemia per 100 person years for different levels of eGFR and albuminuria, as well as by certain comorbidities (Supplementary Table 1) [21]
Potential claims generally involve medications containing the active ingredient semaglutide or tirzepatide, including Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound
The updated consensus statement for management of exercise in type 1 diabetes highlights very detailed suggestions regarding the use of trend arrows and adjustment of insulin doses and carbohydrate intake [149]
But the big advantage of GLP-1s is that they not only help with insulin sensitivity (thereby lowering blood sugar), but they support weight loss too
Contact us today to schedule your free consultation
:max_bytes(150000):strip_icc():focal(749x0:751x2)/Rachel-McRady-Mom-on-GLP-1-Tout-031726-6e65bdd3fb154ca2b321a950a48e213e.jpg)
